207 related articles for article (PubMed ID: 11431687)
1. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.
Njajou OT; Vaessen N; Joosse M; Berghuis B; van Dongen JW; Breuning MH; Snijders PJ; Rutten WP; Sandkuijl LA; Oostra BA; van Duijn CM; Heutink P
Nat Genet; 2001 Jul; 28(3):213-4. PubMed ID: 11431687
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E
Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899
[TBL] [Abstract][Full Text] [Related]
3. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
[TBL] [Abstract][Full Text] [Related]
4. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.
Montosi G; Donovan A; Totaro A; Garuti C; Pignatti E; Cassanelli S; Trenor CC; Gasparini P; Andrews NC; Pietrangelo A
J Clin Invest; 2001 Aug; 108(4):619-23. PubMed ID: 11518736
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
[TBL] [Abstract][Full Text] [Related]
6. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
7. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.
Lee PL; Gelbart T; West C; Halloran C; Felitti V; Beutler E
Blood Cells Mol Dis; 2001; 27(5):783-802. PubMed ID: 11783942
[TBL] [Abstract][Full Text] [Related]
8. G80S-linked ferroportin disease: the first clinical description in a Greek family.
Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
[No Abstract] [Full Text] [Related]
9. Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics.
Njajou OT; de Jong G; Berghuis B; Vaessen N; Snijders PJ; Goossens JP; Wilson JH; Breuning MH; Oostra BA; Heutink P; Sandkuijl LA; van Duijn CM
Blood Cells Mol Dis; 2002; 29(3):439-43. PubMed ID: 12547233
[TBL] [Abstract][Full Text] [Related]
10. Nramp2 analysis in hemochromatosis probands.
Le Gac G; Mura C; Raguenes O; Mercier AY; de Braekeleer M; Férec C
Blood Cells Mol Dis; 2000 Aug; 26(4):312-9. PubMed ID: 11042033
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
[TBL] [Abstract][Full Text] [Related]
12. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
[TBL] [Abstract][Full Text] [Related]
13. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis.
Delatycki MB; Allen KJ; Gow P; MacFarlane J; Radomski C; Thompson J; Hayden MR; Goldberg YP; Samuels ME
Clin Genet; 2004 May; 65(5):378-83. PubMed ID: 15099344
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary hemocromatosis].
Franchini M; Veneri D
Recenti Prog Med; 2004 Oct; 95(10):457-62. PubMed ID: 15560291
[TBL] [Abstract][Full Text] [Related]
15. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic expression of ferroportin disease in a family with the N144H mutation.
Rosmorduc O; Wendum D; Arrivé L; Elnaggar A; Ennibi K; Hannoun L; Charlotte F; Grangé JD; Poupon R
Gastroenterol Clin Biol; 2008 Mar; 32(3):321-7. PubMed ID: 18403150
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
18. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent.
Le Gac G; Mons F; Jacolot S; Scotet V; Férec C; Frébourg T
Br J Haematol; 2004 Jun; 125(5):674-8. PubMed ID: 15147384
[TBL] [Abstract][Full Text] [Related]
19. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
20. [Genetics of hereditary iron overload].
Le Gall JY; Jouanolle AM; Fergelot P; Mosser J; David V
Bull Acad Natl Med; 2004; 188(2):247-62; discussion 262-3. PubMed ID: 15506716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
